{"title":"Industry Embraces Precision Clinical Trials","authors":"James Michael Causey","doi":"10.14524/CR-16-4031","DOIUrl":null,"url":null,"abstract":"In this article, Clinical Researcher ’s editor-in-chief presents insights from a variety of experts on how the adoption of precision clinical trials and the pursuit of personalized medicines are ascendant and inextricably linked, and how neither shows any signs of losing altitude any time soon.","PeriodicalId":90809,"journal":{"name":"Clinical researcher (Alexandria, Va.)","volume":"200 1","pages":"56-57"},"PeriodicalIF":0.0000,"publicationDate":"2016-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical researcher (Alexandria, Va.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14524/CR-16-4031","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
In this article, Clinical Researcher ’s editor-in-chief presents insights from a variety of experts on how the adoption of precision clinical trials and the pursuit of personalized medicines are ascendant and inextricably linked, and how neither shows any signs of losing altitude any time soon.